Azimuth Capital Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.03M | Buy |
114,975
+5,010
| +5% | +$350K | 0.3% | 120 |
|
|
2025
Q1 | $8.08M | Sell |
109,965
-9,610
| -8% | -$706K | 0.32% | 117 |
|
|
2024
Q4 | $7.83M | Buy |
119,575
+69,005
| +136% | +$4.52M | 0.3% | 108 |
|
|
2024
Q3 | $3.94M | Buy |
+50,570
| New | +$3.94M | 0.15% | 160 |
|
|
2023
Q3 | – | Sell |
-63,820
| Closed | -$4.57M | – | 292 |
|
|
2023
Q2 | $4.57M | Sell |
63,820
-1,375
| -2% | -$98.4K | 0.22% | 144 |
|
|
2023
Q1 | $4.53M | Sell |
65,195
-1,485
| -2% | -$103K | 0.22% | 146 |
|
|
2022
Q4 | $4.52M | Sell |
66,680
-1,555
| -2% | -$105K | 0.23% | 142 |
|
|
2022
Q3 | $3.74M | Sell |
68,235
-2,730
| -4% | -$150K | 0.2% | 155 |
|
|
2022
Q2 | $4.69M | Buy |
+70,965
| New | +$4.69M | 0.24% | 140 |
|